Next 10 |
home / stock / nvytf / nvytf news
2023-09-28 17:32:10 ET Novacyt S.A. (NVYTF) Q2 2023 Earnings Conference Call September 28, 2023 07:30 AM ET Company Participants James McCarthy - Acting CEO Steve Gibson - Group Finance Director Lyn Rees - Executive Director Conference Call Participants ...
2023-04-29 10:40:21 ET Novacyt S.A. (NVYTF) Q4 2022 Results Conference Call April 27, 2023 07:00 AM ET Company Participants James McCarthy - Acting Chief Executive Officer Steve Gibson - Group Finance Director Presentation Operator Good afternoon,...
2023-04-27 13:47:49 ET Novacyt S.A. ( OTCPK:NVYTF ): FY GAAP EPS of -£0.36. Revenue of £21M (-78.1% Y/Y). For further details see: Novacyt S.A. GAAP EPS of -£0.36, revenue of £21M
The following slide deck was published by Novacyt S.A. in conjunction with their 2022 Q2 earnings call. For further details see: Novacyt S.A. 2022 Q2 - Results - Earnings Call Presentation
Novacyt S.A. (NVYTF) Q2 2022 Earnings Conference Call September 29, 2022 7:00 A.M. ET Company Participants David Allmond - Chief Executive Officer James McCarthy - Chief Financial Officer Conference Call Participants Presentation Operator ...
Novacyt S.A. press release ( OTCPK:NVYTF ): 1H GAAP EPS of -£0.12. Revenue of £16.5M (-68.4% Y/Y). Group adjusted EBITDA loss of £7.1M in H1 2022 before exceptionals (H1 2021: £23.6M profit). Cash position at 30 June 2022 was £99.6M (FY 2021: &...
Novacyt S.A. press release (OTCPK:NVYTF): FY Non-GAAP EPS of -€0.14. Revenue of €95.78M (-65.4% Y/Y). For further details see: Novacyt S.A. Non-GAAP EPS of -€0.14, revenue of €95.78M
Novacyt S.A. (NVYTF): FY GAAP EPS of £1.94.Revenue of £277.2M (+2310.4% Y/Y)Gross margin increased to 76.3% in 2020 from 64.0% in 2019.EBITDA increased to £176.1M in 2020 compared with £0.2m in last year.Press Release For further details see: Novacyt S.A. r...
Novacyt ([[NVYTF]] -36.3%) has lost more than a third after announcing a possible termination of the contract with the UK Department of Health and Social Care (“DHSC”) to supply COVID-19 Direct kits and other products.Cautioning a ‘material impact’ on Q4 2020 ...
Aimed a supporting the National Health Service's needs for COVID-19 testing, Novacyt (NVYTF) inks a new supply contract with the U.K. Department of Health and Social Care ((DHSC)) for its q16 and q32 Rapid-PCR instrument platforms, exsig COVID-19 Direct kits and genesig SARS-CoV-2 W...